A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples